# A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

> **NCT00142350** · PHASE3 · COMPLETED · sponsor: **Japan Clinical Oncology Group** · enrollment: 690 (—)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** continuous infusion of 5-fluorouracil
- **DRUG:** combination of irinotecan and cisplatin
- **DRUG:** oral administration of S-1

## Key facts

- **NCT ID:** NCT00142350
- **Lead sponsor:** Japan Clinical Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 690 (—)
- **Last updated:** 2016-09-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142350, "A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00142350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*